New seven-part series explores disparities in care, funding
and innovation impacting half the world's population
LONDON, Nov. 21,
2024 /PRNewswire/
-- BioWorld™ published by Clarivate
Plc (NYSE:CLVT), a leading global provider of
transformative intelligence, has launched its new special series,
'Healing the Health Divide.' This seven-part series
sheds light on the persistent disparities in women's health
research, funding, and treatment.
Women make up half of the global population, yet their health
remains consistently underserved. Research and treatments have
traditionally focused on reproduction and breast health, but these
areas represent just a fraction of the broader health challenges
women face. From autoimmune disorders to cardiovascular disease,
many conditions disproportionately affect women or manifest
differently than in men. However, decades of research have excluded
women from clinical trials, often due to misconceptions about their
"complex physiology." Meanwhile, male-dominated boardrooms have
perpetuated this oversight in funding decisions, exacerbating the
issue.
The consequences of this systemic neglect are stark. In 2023,
just 15% of venture capital funding was directed to biopharma
companies focused on women's health, and only 8% of funded
companies included women's health assets in their pipelines. These
disparities leave critical gaps in care for conditions such as
Alzheimer's disease, which affects women at twice the rate of men,
and endometriosis, which impacts approximately 190 million women
worldwide, yet often goes undiagnosed for years.
Lynn Yoffee, Publisher of
BioWorld, stated: "The new BioWorld special series,
'Healing the Health Divide,' is a call to action to address
the inequities in women's health research and investment. The data
we've uncovered highlights the urgent need for a paradigm shift in
how we approach this critical issue. This series not only exposes
the disparities but also celebrates the progress being made, with
the goal of inspiring industry leaders and scientists to close
these gaps and create solutions that benefit all of humanity."
The series explores underrecognized areas such as the role of
gender bias in research, the untapped potential of women's health
markets, and groundbreaking efforts to improve early diagnosis and
treatment of conditions like endometriosis and cardiovascular
disease.
Featured articles in 'Healing the Health Divide,'
include:
- Despite women's health inroads, lackluster funding impedes
progress
Despite increased interest, progress in women's health remains
hindered by lackluster funding and decades of exclusion from
clinical trials. The number of deals focused on women's health
since 2019 comprise just 18.5% of all deals analyzed from the 473
companies and they make up just 20% of the total value of all deals
that disclosed terms. This article, by Senior Managing Editor
Karen Carey explores the inspiring
efforts of women leading the charge to improve health outcomes and
secure investments for female-focused solutions.
- Dynamic infographic on Women's Health
A compelling visual analysis by Production Editor Ann Marie Griffith of women's health funding,
showcases how venture capital and biopharma companies are beginning
to address the vast unmet need — but still have far to go.
- VCs emerge for women's health and its 'groundbreaking'
research
While U.S. government initiatives are supportive, private market
investments are essential to advance women's health innovations.
This article highlights emerging venture capital efforts and the
challenges of securing funding.
- The science of gender-based medicine: many reasons, many
manifestations
From Alzheimer's to autoimmune diseases, Managing Editor
Anette Breindl, examines how
biological and hormonal differences impact disease prevalence and
progression in women, emphasizing the importance of gender-specific
medical research.
- Gender bias leaves women at risk in cardiology treatment
guidelines
Gender bias in cardiac care has left nearly 70% of women
underdiagnosed for cardiovascular disease. Staff Writer
Tamra Sami investigates how
male-focused clinical trials have skewed treatment guidelines,
endangering women's lives.
- Holistic strategies needed to diagnose and treat
endometriosis
Endometriosis affects 10% of women globally, yet delayed diagnosis
and limited understanding have left millions suffering
unnecessarily. This article, also produced by Sami, delves into the
biological complexity of the disease and the need for comprehensive
treatment strategies.
- New diagnostics, trials address deadly disparities in
women's cardiac care
While women with "big hearts" play well in popular culture,
cardiologists see a very different picture – with significant
implications for women's health and medical care, according to an
article by Editor Annette Boyle.
Women have smaller hearts and smaller blood vessels than men and
their cardiovascular systems respond to disease and treatment in
very different ways. In 2024, for the first time, major trials of
cardiovascular medical devices sought to understand how common
interventions work in women and how previous failures to include
women in studies translated into higher cardiovascular mortality
rates.
BioWorld's "Healing the Health Divide" underscores the
urgent need for equitable investment in women's health and
celebrates the pioneers driving meaningful change.
To access the full special series, visit
https://www.bioworld.com/womens_health.
Join the conversation and mention BioWorld
on X and LinkedIn as
well as Clarivate for Life Sciences & Healthcare
on X and LinkedIn.
About BioWorld
With writers and editors stationed around the globe, BioWorld
published by Clarivate, reports the breaking news - and provides
key perspective on hundreds of therapeutics and devices in
development, the companies behind those candidates, the business
development transactions that evolve the markets, and the
regulatory hurdles that both challenge and guard the processes.
BioWorld has a long tradition of excellence in journalism.
Collectively, the news services have been honored with 61 awards
dating back to 1998.
About Clarivate
Clarivate™ is a leading global provider of transformative
intelligence. We offer enriched data, insights & analytics,
workflow solutions and expert services in the areas of Academia
& Government, Intellectual Property and Life Sciences &
Healthcare. For more information, please
visit www.clarivate.com
Media Contact
Catherine Daniel
Director, External Communications, Life Sciences & Healthcare,
Clarivate
newsroom@clarivate.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/bioworld-by-clarivate-highlights-gaps-in-womens-health-research-and-investment-in-new-special-series-302312175.html
SOURCE Clarivate Plc